Inactive Instrument

News Anchiano Therapeutics Ltd.

Equities

ANCN

US03280X1028

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

ANCHIANO THERAPEUTICS LTD. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	21-03-17	AQ
DJ Industrial : Wall Street Narrowly Mixed; Data, Fed Rate Meeting in Focus	21-03-16	MT
Anchiano Therapeutics : Shareholders OK Pending Chemomab Merger	21-03-16	MT
Anchiano Therapeutics Ltd.(NasdaqCM:ANCN) dropped from NASDAQ Composite Index	21-03-16	CI
ChemomAb Ltd. completed the acquisition of Anchiano Therapeutics Ltd. in a reverse merger transaction.	21-03-15	CI
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing	21-03-15	GL
ANCHIANO THERAPEUTICS LTD. : Other Events (form 8-K)	21-03-10	AQ
ANCHIANO THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	21-03-09	AQ
Anchiano Therapeutics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-09	CI
Anchiano Therapeutics Ltd. Auditor Raises 'Going Concern' Doubt	21-03-08	CI
ANCHIANO THERAPEUTICS LTD. : Other Events (form 8-K)	21-02-08	AQ
ANCHIANO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Anchiano Therapeutics Ltd. - ANCN	21-01-16	BU
ANCHIANO THERAPEUTICS LTD. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	20-12-15	AQ
Anchiano Therapeutics : Chemomab Plan Merger to Advance Treatment for Fibrosis-Related Diseases	20-12-15	MT
Anchiano Therapeutics : and Chemomab Announce Entry Into Definitive Merger Agreement	20-12-15	AQ
Anchiano Therapeutics Ltd. and Chemomab Ltd. Announce Executive Appointments	20-12-15	CI
ChemomAb Ltd. entered into letter of intent to acquire Anchiano Therapeutics Ltd. for for $27.2 million in a reverse merger transaction.	20-12-14	CI
Anchiano Therapeutics Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-16	CI
ANCHIANO THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-11-16	AQ
ANCHIANO THERAPEUTICS LTD. : Change in Directors or Principal Officers (form 8-K)	20-10-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Anchiano Therapeutics Ltd.

Equities

ANCN

US03280X1028

Summary

Filters